Allogene Therapeutics names Zachary Roberts CEO; Geoffrey Parker retires Nov 6, 2026
Allogene Therapeutics elevated Chief Medical Officer and President Zachary Roberts to CEO, succeeding David Chang. CFO Geoffrey Parker will retire Nov. 6, 2026 but remain to lead finance during an external search for a replacement.